From reactive to predictive: Advancing biologic dosing in dermatology. (PubMed, J Eur Acad Dermatol Venereol) - Nov 14, 2025 - "Model-informed precision dosing represents a paradigm shift in biologic therapy management, moving from standardised to dynamic, patient-centric dosing. By combining real-time monitoring, digital tools, and biological profiling, MIPD has the potential to maximise clinical response, minimise toxicity, and enhance the sustainability of long-term biologic treatment in dermatology."
Journal • Review • Dermatology • Immunology
|
|
Anke Eylenbosch; Catherine Smith; Jo Lambert; Joseph F Standing; Rani Soenen; Ruoheng Wei; Satveer Mahil
|